Reducing peritonitis risk to make home dialysis safer and more accessible
Relavo is a female-founded medical device company dedicated to making home dialysis more accessible by reducing the risk of peritonitis — a life-threatening infection that prevents up to 80% of dialysis patients from receiving care at home. The company's flagship product, PeritoneX, is an in-line connection device that internally disinfects peritoneal dialysis tubes at all connection sites using a vacuum mechanism to flush 0.55% sodium hypochlorite into the connection space. Relavo was founded out of Johns Hopkins University in 2019 by CEO Sarah Lee, CTO Tejasvi Desai, and Chief Innovation Officer Anna Bailey. The company has received support from NSF SBIR ($1M grant), the National Kidney Foundation Innovation Fund, KidneyX, Medtech Innovator, MassChallenge, VentureWell, and additional private investors, raising a total of approximately $1.55M.
Create a free account to see funding visualizations and detailed round data.
Create Free AccountNo funding data available yet.
Know something? Help us improve our data.
Create a free account to see which investors have funded this company.
Clinical-stage medical technology company developing neural-engineering implants and platforms to...
Implantable neuromodulation device targeting the vagus nerve to treat chronic inflammatory diseas...
Implantable shock absorber (ISA) that unloads the knee, relieves pain, and improves function for ...
Galvanize Therapeutics is a leader in energy-based medical device technology that impacts biologi...
Percutaneous radiofrequency procedure to ablate the basivertebral nerve for the treatment of chro...
Develops an automated benchtop blood-testing analyzer that delivers lab-accurate routine blood te...
